Muskiet F - Search Results

1

N-acetylcysteine reduces oxidative stress in sickle cell patients.

Nur E, Brandjes DP, Teerlink T, Otten HM, Oude Elferink RP, Muskiet F, Evers LM, ten Cate H, Biemond BJ, Duits AJ, Schnog JJ; CURAMA study group. Nur E, et al. Among authors: muskiet f. Ann Hematol. 2012 Jul;91(7):1097-105. doi: 10.1007/s00277-011-1404-z. Epub 2012 Feb 10. Ann Hematol. 2012. PMID: 22318468 Free PMC article. Clinical Trial.

2

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease.

Schnog JB, Teerlink T, van der Dijs FP, Duits AJ, Muskiet FA; CURAMA Study Group. Schnog JB, et al. Among authors: muskiet fa. Ann Hematol. 2005 May;84(5):282-6. doi: 10.1007/s00277-004-0983-3. Epub 2004 Dec 14. Ann Hematol. 2005. PMID: 15599544

3

Optimization of folic acid, vitamin B(12), and vitamin B(6) supplements in pediatric patients with sickle cell disease.

van der Dijs FP, Fokkema MR, Dijck-Brouwer DA, Niessink B, van der Wal TI, Schnog JJ, Duits AJ, Muskiet FD, Muskiet FA. van der Dijs FP, et al. Am J Hematol. 2002 Apr;69(4):239-46. doi: 10.1002/ajh.10083. Am J Hematol. 2002. PMID: 11921017 Free article.

4

Evidence for a metabolic shift of arginine metabolism in sickle cell disease.

Schnog JJ, Jager EH, van der Dijs FP, Duits AJ, Moshage H, Muskiet FD, Muskiet FA. Schnog JJ, et al. Ann Hematol. 2004 Jun;83(6):371-5. doi: 10.1007/s00277-004-0856-9. Epub 2004 Mar 31. Ann Hematol. 2004. PMID: 15054669

5

Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis.

Landburg PP, Teerlink T, Muskiet FA, Duits AJ, Schnog JJ; CURAMA study group. Landburg PP, et al. Am J Hematol. 2008 Jul;83(7):577-9. doi: 10.1002/ajh.21184. Am J Hematol. 2008. PMID: 18383318 Free article.

6

Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertension.

van Beers EJ, Nur E, Schaefer-Prokop CM, Mac Gillavry MR, van Esser JW, Brandjes DP, Kappers-Klunne MC, Duits AJ, Muskiet FA, Schnog JJ, Biemond BJ; CURAMA Study Group. van Beers EJ, et al. Am J Hematol. 2008 Nov;83(11):850-4. doi: 10.1002/ajh.21272. Am J Hematol. 2008. PMID: 18819095 Free article.

7

Sickle cell disease; a general overview.

Schnog JB, Duits AJ, Muskiet FA, ten Cate H, Rojer RA, Brandjes DP. Schnog JB, et al. Among authors: muskiet fa. Neth J Med. 2004 Nov;62(10):364-74. Neth J Med. 2004. PMID: 15683091 Free article. Review.

8

Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis.

van Tits LJ, van Heerde WL, Landburg PP, Boderie MJ, Muskiet FA, Jacobs N, Duits AJ, Schnog JB. van Tits LJ, et al. Among authors: muskiet fa. Biochem Biophys Res Commun. 2009 Dec 4;390(1):161-4. doi: 10.1016/j.bbrc.2009.09.102. Epub 2009 Sep 30. Biochem Biophys Res Commun. 2009. PMID: 19799864

9

Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype.

Landburg PP, Teerlink T, Biemond BJ, Brandjes DP, Muskiet FA, Duits AJ, Schnog JB; CURAMA study group. Landburg PP, et al. Among authors: muskiet fa. Blood Cells Mol Dis. 2010 Apr 15;44(4):229-32. doi: 10.1016/j.bcmd.2010.02.005. Epub 2010 Feb 24. Blood Cells Mol Dis. 2010. PMID: 20185345

10

New concepts in assessing sickle cell disease severity.

Schnog JJ, Lard LR, Rojer RA, Van der Dijs FP, Muskiet FA, Duits AJ. Schnog JJ, et al. Among authors: muskiet fa. Am J Hematol. 1998 May;58(1):61-6. doi: 10.1002/(sici)1096-8652(199805)58:1<61::aid-ajh11>3.0.co;2-8. Am J Hematol. 1998. PMID: 9590151 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

327 results

Search Page